Pharmaceuticals, Biotechnology and Life Sciences
Matt Clark named new Chief Executive Officer US-based X-Chem is the leading provider of small molecule discovery services to global…
FDA allowed FSD Pharma to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
NodThera has secured $55 million (£44 million) in a Series B financing. NodThera’s lead candidate, NT-0167, is being evaluated in a Phase 1 clinical trial in healthy volunteers.
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 1, 2020 the Compensation Committee of…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…
NEW YORK–(BUSINESS WIRE)–Treadwell Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that the U.S.…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation…
Funding to Support its Breakthrough Therapy and Telemedicine Solutions for People Living with Insulin-Requiring Type 1 and Type 2 Diabetes…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Drug Delivery Market by Route of Administration and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026” report…
DUBLIN–(BUSINESS WIRE)–The “Biotechnology Reagents – Global Market Outlook (2018-2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Biotechnology Reagents…